Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Influenza Drugs and Vaccines, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Influenza Drugs and Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Influenza Drugs and Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Type
    • 1.4.2 Zanamivir
    • 1.4.3 Oseltamivir Phosphate
    • 1.4.4 Peramivir
    • 1.4.5 Trivalent
    • 1.4.6 Quadrivalent
  • 1.5 Market by Application
    • 1.5.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Research Laboratories
    • 1.5.4 Pharmacies
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Influenza Drugs and Vaccines Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Influenza Drugs and Vaccines Industry
      • 1.6.1.1 Influenza Drugs and Vaccines Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Influenza Drugs and Vaccines Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Influenza Drugs and Vaccines Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Influenza Drugs and Vaccines Market Size Estimates and Forecasts
    • 2.1.1 Global Influenza Drugs and Vaccines Revenue 2015-2026
    • 2.1.2 Global Influenza Drugs and Vaccines Sales 2015-2026
  • 2.2 Influenza Drugs and Vaccines Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Influenza Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Influenza Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Influenza Drugs and Vaccines Competitor Landscape by Players

  • 3.1 Influenza Drugs and Vaccines Sales by Manufacturers
    • 3.1.1 Influenza Drugs and Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Influenza Drugs and Vaccines Revenue by Manufacturers
    • 3.2.1 Influenza Drugs and Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 Influenza Drugs and Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Influenza Drugs and Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Influenza Drugs and Vaccines Revenue in 2019
    • 3.2.5 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Influenza Drugs and Vaccines Price by Manufacturers
  • 3.4 Influenza Drugs and Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 Influenza Drugs and Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Influenza Drugs and Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into Influenza Drugs and Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Influenza Drugs and Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global Influenza Drugs and Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global Influenza Drugs and Vaccines Revenue by Type (2015-2020)
    • 4.1.3 Influenza Drugs and Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Influenza Drugs and Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Influenza Drugs and Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Influenza Drugs and Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 Influenza Drugs and Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Influenza Drugs and Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Influenza Drugs and Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global Influenza Drugs and Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global Influenza Drugs and Vaccines Revenue by Application (2015-2020)
    • 5.1.3 Influenza Drugs and Vaccines Price by Application (2015-2020)
  • 5.2 Influenza Drugs and Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Influenza Drugs and Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Influenza Drugs and Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Influenza Drugs and Vaccines Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Influenza Drugs and Vaccines by Country
    • 6.1.1 North America Influenza Drugs and Vaccines Sales by Country
    • 6.1.2 North America Influenza Drugs and Vaccines Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Influenza Drugs and Vaccines Market Facts & Figures by Type
  • 6.3 North America Influenza Drugs and Vaccines Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Influenza Drugs and Vaccines by Country
    • 7.1.1 Europe Influenza Drugs and Vaccines Sales by Country
    • 7.1.2 Europe Influenza Drugs and Vaccines Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Influenza Drugs and Vaccines Market Facts & Figures by Type
  • 7.3 Europe Influenza Drugs and Vaccines Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Influenza Drugs and Vaccines by Region
    • 8.1.1 Asia Pacific Influenza Drugs and Vaccines Sales by Region
    • 8.1.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Influenza Drugs and Vaccines Market Facts & Figures by Type
  • 8.3 Asia Pacific Influenza Drugs and Vaccines Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Influenza Drugs and Vaccines by Country
    • 9.1.1 Latin America Influenza Drugs and Vaccines Sales by Country
    • 9.1.2 Latin America Influenza Drugs and Vaccines Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Influenza Drugs and Vaccines Market Facts & Figures by Type
  • 9.3 Central & South America Influenza Drugs and Vaccines Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Influenza Drugs and Vaccines by Country
    • 10.1.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Country
    • 10.1.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Type
  • 10.3 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
    • 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
    • 11.1.5 GlaxoSmithKline Recent Development
  • 11.2 Sanofi Pasteur
    • 11.2.1 Sanofi Pasteur Corporation Information
    • 11.2.2 Sanofi Pasteur Description, Business Overview and Total Revenue
    • 11.2.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Sanofi Pasteur Influenza Drugs and Vaccines Products Offered
    • 11.2.5 Sanofi Pasteur Recent Development
  • 11.3 CSL Limited
    • 11.3.1 CSL Limited Corporation Information
    • 11.3.2 CSL Limited Description, Business Overview and Total Revenue
    • 11.3.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 CSL Limited Influenza Drugs and Vaccines Products Offered
    • 11.3.5 CSL Limited Recent Development
  • 11.4 Astrazeneca
    • 11.4.1 Astrazeneca Corporation Information
    • 11.4.2 Astrazeneca Description, Business Overview and Total Revenue
    • 11.4.3 Astrazeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Astrazeneca Influenza Drugs and Vaccines Products Offered
    • 11.4.5 Astrazeneca Recent Development
  • 11.5 Protein Sciences Corporation
    • 11.5.1 Protein Sciences Corporation Corporation Information
    • 11.5.2 Protein Sciences Corporation Description, Business Overview and Total Revenue
    • 11.5.3 Protein Sciences Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Protein Sciences Corporation Influenza Drugs and Vaccines Products Offered
    • 11.5.5 Protein Sciences Corporation Recent Development
  • 11.6 Serum Institute Of India Pvt. Ltd.
    • 11.6.1 Serum Institute Of India Pvt. Ltd. Corporation Information
    • 11.6.2 Serum Institute Of India Pvt. Ltd. Description, Business Overview and Total Revenue
    • 11.6.3 Serum Institute Of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Products Offered
    • 11.6.5 Serum Institute Of India Pvt. Ltd. Recent Development
  • 11.7 Emergent Biosolutions
    • 11.7.1 Emergent Biosolutions Corporation Information
    • 11.7.2 Emergent Biosolutions Description, Business Overview and Total Revenue
    • 11.7.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Emergent Biosolutions Influenza Drugs and Vaccines Products Offered
    • 11.7.5 Emergent Biosolutions Recent Development
  • 11.8 Emergent Biosolutions
    • 11.8.1 Emergent Biosolutions Corporation Information
    • 11.8.2 Emergent Biosolutions Description, Business Overview and Total Revenue
    • 11.8.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Emergent Biosolutions Influenza Drugs and Vaccines Products Offered
    • 11.8.5 Emergent Biosolutions Recent Development
  • 11.9 BioCryst Pharmaceuticals.Inc.
    • 11.9.1 BioCryst Pharmaceuticals.Inc. Corporation Information
    • 11.9.2 BioCryst Pharmaceuticals.Inc. Description, Business Overview and Total Revenue
    • 11.9.3 BioCryst Pharmaceuticals.Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Products Offered
    • 11.9.5 BioCryst Pharmaceuticals.Inc. Recent Development
  • 11.10 Alvogen
    • 11.10.1 Alvogen Corporation Information
    • 11.10.2 Alvogen Description, Business Overview and Total Revenue
    • 11.10.3 Alvogen Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Alvogen Influenza Drugs and Vaccines Products Offered
    • 11.10.5 Alvogen Recent Development
  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
    • 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
    • 11.1.5 GlaxoSmithKline Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Influenza Drugs and Vaccines Market Estimates and Projections by Region
    • 12.1.1 Global Influenza Drugs and Vaccines Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Influenza Drugs and Vaccines Revenue Forecast by Regions 2021-2026
  • 12.2 North America Influenza Drugs and Vaccines Market Size Forecast (2021-2026)
    • 12.2.1 North America: Influenza Drugs and Vaccines Sales Forecast (2021-2026)
    • 12.2.2 North America: Influenza Drugs and Vaccines Revenue Forecast (2021-2026)
    • 12.2.3 North America: Influenza Drugs and Vaccines Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Influenza Drugs and Vaccines Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Influenza Drugs and Vaccines Sales Forecast (2021-2026)
    • 12.3.2 Europe: Influenza Drugs and Vaccines Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Influenza Drugs and Vaccines Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Influenza Drugs and Vaccines Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Influenza Drugs and Vaccines Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Influenza Drugs and Vaccines Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Influenza Drugs and Vaccines Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Influenza Drugs and Vaccines Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Influenza Drugs and Vaccines Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Influenza Drugs and Vaccines Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Influenza Drugs and Vaccines Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Influenza Drugs and Vaccines Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Influenza Drugs and Vaccines Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Influenza Drugs and Vaccines Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Influenza Drugs and Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Influenza Drugs and Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Influenza Drugs and Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Influenza Drugs and Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Influenza Drugs and Vaccines market is segmented into
    Zanamivir
    Oseltamivir Phosphate
    Peramivir
    Trivalent
    Quadrivalent

    Segment by Application, the Influenza Drugs and Vaccines market is segmented into
    Hospitals
    Research Laboratories
    Pharmacies
    Others

    Regional and Country-level Analysis
    The Influenza Drugs and Vaccines market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Influenza Drugs and Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Influenza Drugs and Vaccines Market Share Analysis
    Influenza Drugs and Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza Drugs and Vaccines business, the date to enter into the Influenza Drugs and Vaccines market, Influenza Drugs and Vaccines product introduction, recent developments, etc.
    The major vendors covered:
    GlaxoSmithKline
    Sanofi Pasteur
    CSL Limited
    Astrazeneca
    Protein Sciences Corporation
    Serum Institute Of India Pvt. Ltd.
    Emergent Biosolutions
    Emergent Biosolutions
    BioCryst Pharmaceuticals.Inc.
    Alvogen
    ABPI

    Buy now